CERT Quote, Financials, Valuation and Earnings

DarioHealth Corp. has a net margin of 1.46% compared to Certara, Inc.'s net margin of -41.48%. Certara, Inc.'s return on equity of 1.02% beat DarioHealth Corp.'s return on equity of -41.55%.

Certara, Inc. has a consensus price target of $12.38, signalling upside risk potential of 22.4%. On the other hand DarioHealth Corp. has an analysts' consensus of $18.00 which suggests that it could grow by 57.9%. Given that DarioHealth Corp. has higher upside potential than Certara, Inc., analysts believe DarioHealth Corp. is more attractive than Certara, Inc..

Certara, Inc. has a beta of 1.461, which suggesting that the stock is 46.086% more volatile than S&P 500. In comparison DarioHealth Corp. has a beta of 1.047, suggesting its more volatile than the S&P 500 by 4.689%.

Certara, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Certara, Inc. pays -- of its earnings as a dividend. DarioHealth Corp. pays out -- of its earnings as a dividend.

Certara, Inc. quarterly revenues are $104.6M, which are larger than DarioHealth Corp. quarterly revenues of $5M. Certara, Inc.'s net income of $1.5M is higher than DarioHealth Corp.'s net income of -$2.1M. Notably, Certara, Inc.'s price-to-earnings ratio is 149.78x while DarioHealth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Certara, Inc. is 3.92x versus 6.33x for DarioHealth Corp.. Usually stocks with elevated PS ratios are considered overvalued.

GoodRx Holdings, Inc. has a net margin of 1.46% compared to Certara, Inc.'s net margin of 0.57%. Certara, Inc.'s return on equity of 1.02% beat GoodRx Holdings, Inc.'s return on equity of 4.78%.

Certara, Inc. has a consensus price target of $12.38, signalling upside risk potential of 22.4%. On the other hand GoodRx Holdings, Inc. has an analysts' consensus of $4.56 which suggests that it could grow by 80.98%. Given that GoodRx Holdings, Inc. has higher upside potential than Certara, Inc., analysts believe GoodRx Holdings, Inc. is more attractive than Certara, Inc..

Certara, Inc. has a beta of 1.461, which suggesting that the stock is 46.086% more volatile than S&P 500. In comparison GoodRx Holdings, Inc. has a beta of 1.455, suggesting its more volatile than the S&P 500 by 45.545%.

Certara, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. GoodRx Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Certara, Inc. pays -- of its earnings as a dividend. GoodRx Holdings, Inc. pays out -- of its earnings as a dividend.

Certara, Inc. quarterly revenues are $104.6M, which are smaller than GoodRx Holdings, Inc. quarterly revenues of $196M. Certara, Inc.'s net income of $1.5M is higher than GoodRx Holdings, Inc.'s net income of $1.1M. Notably, Certara, Inc.'s price-to-earnings ratio is 149.78x while GoodRx Holdings, Inc.'s PE ratio is 29.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Certara, Inc. is 3.92x versus 1.16x for GoodRx Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

National Research Corp. has a net margin of 1.46% compared to Certara, Inc.'s net margin of 11.54%. Certara, Inc.'s return on equity of 1.02% beat National Research Corp.'s return on equity of 61.55%.

Certara, Inc. has a consensus price target of $12.38, signalling upside risk potential of 22.4%. On the other hand National Research Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Certara, Inc. has higher upside potential than National Research Corp., analysts believe Certara, Inc. is more attractive than National Research Corp..

Certara, Inc. has a beta of 1.461, which suggesting that the stock is 46.086% more volatile than S&P 500. In comparison National Research Corp. has a beta of 0.473, suggesting its less volatile than the S&P 500 by 52.662%.

Certara, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. National Research Corp. offers a yield of 2.5% to investors and pays a quarterly dividend of $0.16 per share. Certara, Inc. pays -- of its earnings as a dividend. National Research Corp. pays out 45.99% of its earnings as a dividend. National Research Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Certara, Inc. quarterly revenues are $104.6M, which are larger than National Research Corp. quarterly revenues of $34.6M. Certara, Inc.'s net income of $1.5M is lower than National Research Corp.'s net income of $4M. Notably, Certara, Inc.'s price-to-earnings ratio is 149.78x while National Research Corp.'s PE ratio is 29.52x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Certara, Inc. is 3.92x versus 3.41x for National Research Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Spok Holdings, Inc. has a net margin of 1.46% compared to Certara, Inc.'s net margin of 9.46%. Certara, Inc.'s return on equity of 1.02% beat Spok Holdings, Inc.'s return on equity of 10.88%.

Certara, Inc. has a consensus price target of $12.38, signalling upside risk potential of 22.4%. On the other hand Spok Holdings, Inc. has an analysts' consensus of $20.00 which suggests that it could grow by 55.21%. Given that Spok Holdings, Inc. has higher upside potential than Certara, Inc., analysts believe Spok Holdings, Inc. is more attractive than Certara, Inc..

Certara, Inc. has a beta of 1.461, which suggesting that the stock is 46.086% more volatile than S&P 500. In comparison Spok Holdings, Inc. has a beta of 0.416, suggesting its less volatile than the S&P 500 by 58.432%.

Certara, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings, Inc. offers a yield of 9.24% to investors and pays a quarterly dividend of $0.31 per share. Certara, Inc. pays -- of its earnings as a dividend. Spok Holdings, Inc. pays out 171.77% of its earnings as a dividend.

Certara, Inc. quarterly revenues are $104.6M, which are larger than Spok Holdings, Inc. quarterly revenues of $33.9M. Certara, Inc.'s net income of $1.5M is lower than Spok Holdings, Inc.'s net income of $3.2M. Notably, Certara, Inc.'s price-to-earnings ratio is 149.78x while Spok Holdings, Inc.'s PE ratio is 16.91x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Certara, Inc. is 3.92x versus 2.01x for Spok Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.